| Filed On | Filing |
|---|---|
| 27 Oct 2026 | SCHEDULE 13G/A |
| 16 Sep 2026 |
Form 4: Schellenberg David, Director
Sold 101 shares ($10.1K) · Sold 7,344 shares ($734K) |
| 15 Sep 2026 | 144 |
| 25 Aug 2026 |
Form 4: Hvid Kenneth, Director
Granted 388.2719 Dividend Equivalent Rights |
| 25 Aug 2026 |
Form 4: Schellenberg David, Director
Granted 23.6963 Dividend Equivalent Rights |
| 25 Aug 2026 |
Form 4: Antturi Peter, Director
Granted 17.3485 Dividend Equivalent Rights |
| 24 Aug 2026 |
Form 4: Kapoor Rohit (RK2), Managing Director, Sinagpore
Granted 78.8076 Dividend Equivalent Rights |
| 24 Aug 2026 |
Form 4: Seidelin Mikkel, Chief Commercial Officer
Granted 99.6417 Dividend Equivalent Rights |
| 24 Aug 2026 |
Form 4: Speers Brody, Chief Financial Officer
Granted 93.4227 Dividend Equivalent Rights |
| 18 Aug 2026 |
Form 4: Kapoor Rohit (RK2), Managing Director, Sinagpore
Sold 6,375 shares ($569K) |
| 18 Aug 2026 |
Form 4: Locke Simon Heidi, Director
Sold 741 shares ($66.7K) |
| 18 Aug 2026 | 144/A |
| 18 Aug 2026 | 144 |
| 18 Aug 2026 | 144 |
| 31 Jul 2026 | 6-K |
| 30 Jul 2026 | SCHEDULE 13G |
| 29 Jul 2026 | 6-K |
| 10 Jun 2026 |
Form 4/A: Krediet Rudolph, Director
Received 1,883 shares as a grant or award ($135K) |
| 10 Jun 2026 |
Form 4/A: Semple Alan, Director
Received 1,883 shares as a grant or award ($135K) |
| 10 Jun 2026 |
Form 4/A: Locke Simon Heidi, Director
Received 1,883 shares as a grant or award ($135K) |
Loading...